CASE REPORT
Atypical mycobacterial cervical lymphadenopathy in a 2-year-old girl
 
More details
Hide details
1
Department of Children’s Developmental Defects Surgery and Traumatology, Medical University of Silesia, Katowice, Poland
 
 
Submission date: 2022-09-14
 
 
Final revision date: 2022-12-18
 
 
Acceptance date: 2022-12-19
 
 
Publication date: 2023-06-22
 
 
Pediatr Pol 2023;98(2):166-169
 
KEYWORDS
TOPICS
ABSTRACT
Lymphadenopathy is a common clinical condition in the paediatric population. In 50% of cases it occurs in otherwise healthy children, and in 75% it presents as a localized form. Lymphadenopathy lasting more than 3 months is defined as chronic. Common conditions causing lymph node enlargement include infections, malignancies, and autoimmune disorders. Mycobacteria causing infectious lymphadenopathy are divided into tuberculous and non-tuberculous mycobacteria (NTM). Diagnosing mycobacterial disease is complicated, and definitive surgery is the best treatment option for NTM cervicofacial lymphadenitis. We present a case of a 2-year-old girl with chronic cervical lymphadenopathy, eventually diagnosed as NTM infection. The diagnostic and therapeutic process was complicated, demanding an interdisciplinary approach and several surgical procedures. The treatment was supported by negative pressure therapy.
REFERENCES (13)
1.
Styczyński J. Limfadenopatia u dzieci i dorosłych: zasady postępowania diagnostycznego. Acta Haematol Pol 2019; 50: 98-102.
 
2.
Van Ingen J. Diagnosis of nontuberculous mycobacterial infections. Semin Respir Crit Care Med 2013; 34: 103-109.
 
3.
Zimmermann P, Nigel C, Tebruegge M. Nontuberculous mycobacterial disease in childhood – update on diagnostic approaches and treatment. J Infect 2017; 74: 136-142.
 
4.
Tebruegge M, Pantazidou A, MacGregor D, et al. Nontuberculous mycobacterial disease in children – epidemiology, diagnosis & management at a tertiary center. PLoS ONE 2016; 11: 1-14.
 
5.
Thavagnanam S, McLoughlin LM, Hill C, et al. Atypical mycobacterial infections in children: the case for early diagnosis. Ulster Med J 2006; 75: 192-194.
 
6.
Scott CA, Atkinson SH, Sodha A, et al. Management of lymphadenitis due to non-tuberculous mycobacterial infection in children. Pediatr Surg Int 2012; 28: 461-466.
 
7.
Bayazit YA, Bayazit N Namiduru M. Mycobacterial cervical lymphadenitis. ORL 2004; 66: 275-280.
 
8.
Zimmermann P, Tebruegge M, Curtis N, et al. The management of non-tuberculous cervicofacial lymphadenitis in children: a systemnatic review and meta-analysis. J Infect 2015; 71: 9-18.
 
9.
Lindeboom JA, Kuijper EJ, Bruijnesteijn von Coppenraet ES, et al. Surgical excision versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children: a multicenter, randomized, controlled trial. Clin Infect Dis 2007; 44: 1057-1064.
 
10.
Montague ML, Musheer H, Blair RL. Three cases of atypical mycobacterial cervical adenitis. J R Soc Med 2003; 96: 129-131.
 
11.
Lindeboom JAH. Surgical treatment for nontuberculous mycobacterial (NTM) cervicofacial lymphadenitis in children. J Oral Maxillofac Surg 2012; 70: 345-348.
 
12.
Torretta S, Gaffuri M, Ibba T, et al. Surgical treatment of non- tuberculous mycobacterial lymphadenitis in children: Our experience and a narrative review. Int J Immunopathol Pharmacol 2018; 32: 1-5.
 
13.
Bousfiha A, Moundir A, Tangye SG, et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol 2022; 42: 1508-1520.
 
Journals System - logo
Scroll to top